Marco Londei - Net Worth and Insider Trading

Marco Londei Net Worth

The estimated net worth of Marco Londei is at least $865,319 dollars as of 2024-09-20. Marco Londei is the Chief Medical Officer of AnaptysBio Inc and owns about 22,377 shares of AnaptysBio Inc (ANAB) stock worth over $865,319. Details can be seen in Marco Londei's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marco Londei has not made any transactions after 2019-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marco Londei

To

Marco Londei Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marco Londei owns 1 companies in total, including AnaptysBio Inc (ANAB) .

Click here to see the complete history of Marco Londei’s form 4 insider trades.

Insider Ownership Summary of Marco Londei

Ticker Comapny Transaction Date Type of Owner
ANAB AnaptysBio Inc 2019-06-04 Chief Medical Officer

Marco Londei Latest Holdings Summary

Marco Londei currently owns a total of 1 stock. Marco Londei owns 22,377 shares of AnaptysBio Inc (ANAB) as of June 4, 2019, with a value of $865,319.

Latest Holdings of Marco Londei

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANAB AnaptysBio Inc 2019-06-04 22,377 38.67 865,319

Holding Weightings of Marco Londei


Marco Londei Form 4 Trading Tracker

According to the SEC Form 4 filings, Marco Londei has made a total of 0 transactions in AnaptysBio Inc (ANAB) over the past 5 years. The most-recent trade in AnaptysBio Inc is the sale of 10,060 shares on June 4, 2019, which brought Marco Londei around $734,984.

Insider Trading History of Marco Londei

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marco Londei Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marco Londei Ownership Network

Ownership Network List of Marco Londei

No Data

Ownership Network Relation of Marco Londei

Insider Network Chart

Marco Londei Owned Company Details

What does AnaptysBio Inc do?

Who are the key executives at AnaptysBio Inc?

Marco Londei is the Chief Medical Officer of AnaptysBio Inc. Other key executives at AnaptysBio Inc include General Counsel Eric J Loumeau , Chief Financial Officer Dennis Mulroy , and Chief Medical Officer Paul F. Lizzul .

AnaptysBio Inc (ANAB) Insider Trades Summary

Over the past 18 months, Marco Londei made no insider transaction in AnaptysBio Inc (ANAB). Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 26,687 shares made by Eric J Loumeau , a net sale of 24,965 shares made by Dennis Mulroy , and a net sale of 10,379 shares made by Paul F. Lizzul .

In summary, during the past 3 months, insiders sold 42,390 shares of AnaptysBio Inc (ANAB) in total and bought 273,972 shares, with a net purchase of 231,582 shares. During the past 18 months, 231,737 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 42,235 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AnaptysBio Inc Insider Transactions

No Available Data

Marco Londei Mailing Address

Above is the net worth, insider trading, and ownership report for Marco Londei. You might contact Marco Londei via mailing address: C/o Anaptysbio, Inc., 10421 Pacific Center Court, Suite 200, San Diego Ca 92121.

Discussions on Marco Londei

No discussions yet.